Utah Medical Products reports Q2 2022 results; exhibit text incomplete in filing

UTAH MEDICAL PRODUCTS INC

2022-Q2 EPS reported $2.09 revenue$25,752,000

Press release dated July 26, 2022 attached as Exhibit 99.1.
Exhibit 99.1 includes financial data for Q2 and H1 2022 and forward guidance.
Specific financial figures (revenue, EPS, etc.) not available in provided filing text.
No other material events disclosed in this 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.